Abstract
Pneumonia-induced sepsis is responsible for about 50% of cases in the world. Patients who develop severe sepsis and septic shock present organ dysfunction and elevated plasma cytokine levels, which may lead to death. Clinical scores are important to evaluate the framework of septic patients and are used to predict the syndrome progress, prognostics, and mortality. The objective of the present study was to verify the applicability of a murine clinical score system to experimental sepsis (pneumonia-induced sepsis in male mice) and to correlate it with mortality and bacterial dissemination in different organs. Results demonstrated that animals which present higher clinical scores (>3) are more likely to die. Animals presenting high clinical scores exhibited transient bacteremia and displayed bacterial spreading to different organs such as heart, kidney, liver, and brain. There is a correlation between clinical score and bacterial dissemination and consequently greater risk of death. In addition, animals which showed bacterial dissemination in more than three organs and high clinical scores presented high levels of cytokines (TNF-α, MCP-1, IL-6, and IL-10) in plasma, lung, heart, liver, kidney, and brain. Therefore, our study suggests that (1) severity scores have predictive power in experimental models of sepsis and (2) high concentrations of tissue cytokines may contribute to localized inflammation and be one of the factors responsible for the systemic inflammatory syndrome of sepsis.
Similar content being viewed by others
References
Teles, J.M., E. Silva, G. Westphal, R.C. Filho, and F.R. Machado. 2008. Surviving sepsis campaign in Brazil. Shock 30: 47–52.
GBD 2013 Mortality and Causes of Death Collaborators. 2015. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the global burden of disease study 2013. Lancet 385: 117–171.
Fleischmann, C., A. Scherag, N.K. Adhikari, C.S. Hartog, T. Tsaganos, P. Schlattmann, D.C. Angus, K. Reinhart, and International Forum of Acute Care Trialists. 2016. Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations. American Journal of Respiratory and Critical Care Medicine 193: 259–272.
Lever, A., and I. Mackenzie. 2007. Sepsis: definition, epidemiology, and diagnosis. BMJ 335: 879–883.
Opal, S.M., R.P. Dellinger, J.L. Vincent, H. Masur, and D.C. Angus. 2014. The next generation of sepsis clinical trial designs: what is next after the demise of recombinant human activated protein C? Critical Care Medicine 42: 1714–1721.
Chang, R., and J.B. Holcomb. 2016. Choice of fluid therapy in the initial management of sepsis, severe sepsis, and septic shock. Shock 46: 17–26.
Metnitz, P.G., R.P. Moreno, E. Almeida, B. Jordan, P. Bauer, R.A. Campos, G. Iapichino, D. Edbrooke, M. Capuzzo, J.R. Le Gall, and SAPS 3 Investigators. 2005. SAPS 3—from evaluation of the patient to evaluation of the intensive care unit. Part 1: objectives, methods and cohort description. Intensive Care Medicine 31: 1336–1344.
Vincent, J.L., and R. Moreno. 2010. Clinical review: scoring systems in the critically ill. Critical Care 14: 207.
Serpa, Neto A., M.S. Assunção, A. Pardini, and E. Silva. 2015. Feasibility of transitioning from APACHE II to SAPS III as prognostic model in a Brazilian general intensive care unit: a retrospective study. Sao Paulo Medical Journal 133: 199–205.
Shaver, C.M., and A.R. Hauser. 2004. Relative contributions of Pseudomonas aeruginosa EXOu, EXOs, and EXOt to virulence in the lung. Infection and Immunity 72: 6969–6977.
Machado, G.B., M.C. de Assis, R. Leão, A.M. Saliba, M.C. Silva, J.H. Suassuna, A.V. de Oliveira, and M.C. Plotkowski. 2010. Exou-induced vascular hyperpermeability and platelet activation in the course of experimental Pseudomonas aeruginosa pneumosepsis. Shock 33: 315–321.
Sordi, R., O. Menezes-De-Lima, A.M. Della-Justina, E. Rezende, and J. Assreuy. 2013. Pneumonia-induced sepsis in mice: temporal study of inflammatory and cardiovascular parameters. International Journal of Experimental Patholology 94: 144–155.
Horewicz, V., S. Crestani, R. de Sordi, E. Rezende, and J. Assreuy. 2015. Fpr2/Alx activation reverses LPS-induced vascular hyporeactivity in aorta and increases survival in a pneumosepsis model. European Journal of Pharmacology 746: 267–273.
Bewick, V., L. Cheek, and J. Ball. 2004. Statistics review 13: Receiver operating characteristic curves. Critical Care 8: 508–512.
Youden, W.J. 1950. Index for rating diagnostic tests. Cancer 3: 32–35.
Mayr, F.B., S. Yende, and D.C. Angus. 2014. Epidemiology of severe sepsis. Virulence 5: 4–11.
Czaikoski, P.G., D.C. Nascimento, F. Sônego, A. De Freitas, W.M. Turato, M.A. De Carvalho, R.S. Santos, G.P. De Oliveira, C. Dos Santos Samary, C. Tefe-Silva, J.C. Alves-Filho, S.H. Ferreira, M.A. Rossi, P.R. Rocco, F. Spiller, and F.Q. Cunha. 2013. Heme oxygenase inhibition enhances neutrophil migration into the bronchoalveolar spaces and improves the outcome of murine pneumonia-induced sepsis. Shock 39: 389–396.
De Stoppelaar, S.F., T.A. Claushuis, M.P. Jansen, B. Hou, J.J. Roelofs, C. Van ’T Veer, and T. Van Der Poll. 2015. The role of platelet myd88 in host response during gram-negative sepsis. Journal of Thrombosis and Haemostasis 13: 1709–1720.
de Souza Nogueira, L., M.R. Santos, S.E. Mataloun, and M. Moock. 2007. Nursing activities score: comparison among the index APACHE II and the mortality in patients admitted in intensive care unit. Revista Brasileira de Terapia Intensiva 19: 327–330.
Hwang, S.Y., J.H. Lee, Y.H. Lee, C.K. Hong, A.J. Sung, and Y.C. Choi. 2012. Comparison of the sequential organ failure assessment, acute physiology and chronic health evaluation II scoring system, and trauma and injury severity score method for predicting the outcomes of intensive care unit trauma patients. The American Journal of Emergency Medicine 30: 749–753.
Huet, O., D. Ramsey, S. Miljavec, A. Jenney, C. Aubron, A. Aprico, N. Stefanovic, B. Balkau, G.A. Head, J.B. de Haan, and J.P. Chin-Dusting. 2013. Ensuring animal welfare while meeting scientific aims using a murine pneumonia model of septic shock. Shock 39: 488–494.
Shrum, B., R.V. Anantha, S.X. Xu, M. Donnelly, S.M.M. Haeryfar, J.K. McCormick, and T. Mele. 2014. A robust scoring system to evaluate sepsis severity in an animal model. BMC Research Notes 7: 233–243.
Brun-Buisson, C., F. Doyon, and J. Carlet. 1996. Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and wards of 24 hospitals. French Bacteremia-Sepsis Study Group. American Journal of Respiratory and Critical Care Medicine 154: 617–624.
Yang, S.C., K.M. Liao, C.W. Chen, and W.C. Lin. 2013. Positive blood culture is not associated with increased mortality in patients with sepsis-induced acute respiratory distress syndrome. Respirology 18: 1210–1216.
de Boer, J.D., L.M. Kager, J.J. Roelofs, J.C. Meijers, O.J. de Boer, H. Weiler, B. Isermann, C. van’t Veer, and T. van der Poll. 2014. Overexpression of activated protein C hampers bacterial dissemination during Pneumococcal pneumonia. BMC Infectious Diseases 14: 559–568.
Bellomo, R., C. Ronco, J.A. Kellum, R.L. Mehta, P. Palevsky, and Acute Dialysis Quality Initiative Workgroup. 2004. Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Critical Care 8: 204–212.
Chawla, L.S., P.W. Eggers, R.A. Star, and P.L. Kimmel. 2014. Acute kidney injury and chronic kidney disease as interconnected syndromes. New England Journal Medicine 371: 58–66.
Schortgen, F., and P. Asfar. 2015. Update in sepsis and acute kidney injury. American Journal of Respiratory and Critical Care Medicine 191: 1226–1231.
Linder, A., C. Fjell, A. Levin, K.R. Walley, J.A. Russell, and J.H. Boyd. 2014. Small acute increases in serum creatinine are associated with decreased long-term survival in the critically ill. American Journal of Respiratory and Critical Care Medicine 189: 1075–1081.
Hua, L., J.J. Hilliard, Y. Shi, C. Tkaczyk, L.I. Cheng, X. Yu, V. Datta, S. Ren, H. Feng, R. Zinsou, A. Keller, T. O’day, Q. Du, L. Cheng, M. Damschroder, G. Robbie, J. Suzich, C.K. Stover, and B.R. Sellman. 2014. Assessment of an anti-alpha-toxin monoclonal antibody for prevention and treatment of Staphylococcus aureus-induced pneumonia. Antimicrobials Agents and Chemotherapy 58: 1108–1117.
Kumar, H., T. Kawai, and S. Akira. 2011. Pathogen recognition by the innate immune system. International Reviews of Immunology 30: 16–34.
Beaufort, N., E. Corvazier, A. Hervieu, C. Choqueux, M. Dussiot, L. Louedec, A. Cady, S. De Bentzmann, J.B. Michel, and D. Pidard. 2011. The thermolysin-like metalloproteinase and virulence factor LasB from pathogenic Pseudomonas aeruginosa induces anoikis of human vascular cells. Cellular Microbiology 13: 1149–1167.
Brinkmann, V., U. Reichard, C. Goosmann, B. Fauler, Y. Uhlemann, K.A. Weiss Brown, and D.F. Treacher. 2006. Neutrophils as potential therapeutic targets in sepsis. Discovery Medicine 6: 118–122.
Fuchs, T.A., A. Brill, D. Duerschmied, D. Schatzberg, M. Monestier, D.D. Myers Jr., S.K. Wrobleski, T.W. Wakefield, J.H. Hartwig, and D.D. Wagner. 2010. Extracellular DNA traps promote thrombosis. Proceedings of the National Academy of Sciences 107: 15880–15885.
Augustin, P., G. Alsalih, Y. Launey, S. Delbosc, L. Louedec, V. Ollivier, F. Chau, P. Montravers, X. Duval, J.B. Michel, and O. Meilhac. 2013. Predominant role of host proteases in myocardial damage associated with infectious endocarditis induced by Enterococcus faecalis in a rat model. Infection and Immunity 81: 1721–1729.
Girard, T.D., J.C. Jackson, P.P. Pandharipande, B.T. Pun, J.L. Thompson, A.K. Shintani, S.M. Gordon, A.E. Canonico, R.S. Dittus, G.R. Bernard, and E.W. Ely. 2010. Delirium as a predictor of long-term cognitive impairment in survivors of critical illness. Critical Care Medicine 38: 1513–1520.
Iwashyna, T.J., E.W. Ely, D.M. Smith, and L.M. Langa. 2010. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA 304: 1787–1794.
Damas, P., A. Reuter, P. Gysen, J. Demonty, M. Lamy, and P. Franchimont. 1989. Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Critical Care Medicine 17: 975–978.
Waage, A., T. Espevik, and J. Lamvik. 1986. Detection of tumour necrosis factor-like cytotoxicity in serum from patients with septicaemia but not from untreated cancer patients. Scandinavian Journal of Immunology 24: 739–743.
Michie, H.R., K.R. Manogue, D.R. Spriggs, A. Revhaug, S. O’dwyer, C.A. Dinarello, A. Cerami, S.M. Wolff, and D.W. Wilmore. 1988. Detection of circulating tumor necrosis factor after endotoxin administration. New England Journal of Medicine 318: 1481–1486.
Bozza, F.A., J.I. Salluh, A.M. Japiassu, M. Soares, E.F. Assis, R.N. Gomes, M.T. Bozza, H.C. Castro-Faria-Neto, and P.T. Bozza. 2007. Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Critical Care 11: R49.
Van Den Berg, S., J.D. Laman, L. Boon, M.T. Ten Kate, G.J. de Knegt, R.M. Verdijk, H.A. Verbrugh, J.L. Nouwen, and I.A. Bakker-Woudenberg. 2013. Distinctive cytokines as biomarkers predicting fatal outcome of severe Staphylococcus aureus bacteremia in mice. PloS One 8: E59107.
Kaner, Z., D.E. Ochayon, G. Shahaf, B.M. Baranovski, N. Bahar, M. Mizrahi, and E.C. Lewis. 2015. Acute phase protein α1-antitrypsin reduces the bacterial burden in mice by selective modulation of innate cell responses. Journal of Infectious Diseases 211: 1489–1498.
Zhao, H.Q., W.M. Li, Z.Q. Lu, Z.Y. Sheng, and Y.M. Yao. 2015. The growing spectrum of anti-inflammatory interleukins and their potential roles in the development of sepsis. Journal of Interferon & Cytokine Research 35: 242–251.
Merx, M.W., and C. Weber. 2007. Sepsis and the heart. Circulation 116: 793–802.
Horton, J., D. Maass, J. White, and B. Sanders. 2006. Effect of aspiration pneumonia-induced sepsis on post-burn cardiac inflammation and function in mice. Surgical Infections 7: 123–135.
Hobai, I.A., J.C. Morse, D.A. Siwik, and W.S. Colucci. 2015. Lipopolysaccharide and cytokines inhibit rat cardiomyocyte contractility in vitro. The Journal of Surgical Research 193: 888–901.
Ysebaert, D.K., K.E. de Greef, S.R. Vercauteren, M. Ghielli, G.A. Verpooten, E.J. Eyskens, and M.E. de Broe. 2000. Identification and kinetics of leukocytes after severe ischaemia/reperfusion renal injury. Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association—European Renal Association 15: 1562–1574.
Cogen, A.L., and T.A. Moore. 2009. Beta2-microglobulin-dependent bacterial clearance and survival during murine Klebsiella pneumoniae bacteremia. Infection and Immunity 77: 360–366.
Singer, M., C.S. Deutschman, C.W. Seymour, M. Shankar-Hari, D. Annane, M. Bauer, R. Bellomo, G.R. Bernard, J.D. Chiche, C.M. Coopersmith, R.S. Hotchkiss, M.M. Levy, J.C. Marshall, G.S. Martin, S.M. Opal, G.D. Rubenfeld, T. Van Der Poll, J.L. Vincent, and D.C. Angus. 2016. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 315: 801–810.
Acknowledgements
This work was funded by grants from CNPq, Brazil (grant 474295/2012-5) and FAPESC, Brazil (grant 2014TR1698). The skillful technical assistance of Mrs. Adriane Madeira is gratefully acknowledged. We also thank the technicians of Multiuser Laboratory of Biology Studies (LAMEB-UFSC).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
We declare we do not have any conflict of interest.
Rights and permissions
About this article
Cite this article
Gonçalves, M.C., Horewicz, V.V., Lückemeyer, D.D. et al. Experimental Sepsis Severity Score Associated to Mortality and Bacterial Spreading is Related to Bacterial Load and Inflammatory Profile of Different Tissues. Inflammation 40, 1553–1565 (2017). https://doi.org/10.1007/s10753-017-0596-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-017-0596-3